Literature DB >> 3013264

Reversible renal failure after combined treatment with enalapril and frusemide in a patient with congestive heart failure.

C Funck-Brentano, G Chatellier, J M Alexandre.   

Abstract

A patient with congestive heart failure and moderate renal insufficiency developed severe reversible non-oliguric renal failure while on frusemide and enalapril. Renal failure developed when enalapril was given in the presence of pronounced sodium depletion. When positive sodium balance was restored the plasma creatinine concentration began to fall while angiotensin converting enzyme inhibition remained effective and blood pressure was stable. These observations suggest that the degree of sodium depletion plays an important role in the tendency for angiotensin converting enzyme inhibitors to induce renal failure in patients with congestive heart failure and moderate renal insufficiency. Restoration of a positive sodium balance promotes the recovery of renal function after the combined administration of angiotensin converting enzyme inhibitors and diuretics.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3013264      PMCID: PMC1236768          DOI: 10.1136/hrt.55.6.596

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  13 in total

1.  Captopril and renal autoregulation.

Authors:  W B Blythe
Journal:  N Engl J Med       Date:  1983-02-17       Impact factor: 91.245

2.  Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney.

Authors:  D E Hricik; P J Browning; R Kopelman; W E Goorno; N E Madias; V J Dzau
Journal:  N Engl J Med       Date:  1983-02-17       Impact factor: 91.245

3.  Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure.

Authors:  M A Creager; J L Halperin; D B Bernard; D P Faxon; C D Melidossian; H Gavras; T J Ryan
Journal:  Circulation       Date:  1981-09       Impact factor: 29.690

4.  Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure.

Authors:  V J Dzau; W S Colucci; N K Hollenberg; G H Williams
Journal:  Circulation       Date:  1981-03       Impact factor: 29.690

5.  Effect of captopril on renal function in patients with congestive heart failure.

Authors:  G L Pierpont; G S Francis; J N Cohn
Journal:  Br Heart J       Date:  1981-11

6.  Transient renal dysfunction during initial inhibition of converting enzyme in congestive heart failure.

Authors:  S K Mujais; F M Fouad; S C Textor; R C Tarazi; E L Bravo; N Hart; R W Gifford
Journal:  Br Heart J       Date:  1984-07

7.  Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system.

Authors:  J Biollaz; J L Schelling; B Jacot Des Combes; D B Brunner; G Desponds; H R Brunner; E H Ulm; M Hichens; H J Gomez
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

8.  Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure.

Authors:  V J Dzau; W S Colucci; G H Williams; G Curfman; L Meggs; N K Hollenberg
Journal:  N Engl J Med       Date:  1980-06-19       Impact factor: 91.245

9.  Chronic blockade of angiotensin II formation during sodium deprivation.

Authors:  J E Hall; A C Guyton; M J Smith; T G Coleman
Journal:  Am J Physiol       Date:  1979-12

10.  Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension.

Authors:  T J Moore; F R Crantz; N K Hollenberg; R J Koletsky; M S Leboff; S L Swartz; L Levine; S Podolsky; R G Dluhy; G H Williams
Journal:  Hypertension       Date:  1981 Mar-Apr       Impact factor: 10.190

View more
  3 in total

1.  Reversible renal failure after combined treatment with enalapril and frusemide in a patient with congestive heart failure.

Authors: 
Journal:  Br Heart J       Date:  1986-11

Review 2.  Enalapril. An update of its pharmacological properties and therapeutic use in congestive heart failure.

Authors:  P A Todd; K L Goa
Journal:  Drugs       Date:  1989-02       Impact factor: 9.546

3.  Life-threatening hyperkalaemia in an elderly patient receiving captopril, furosemide (frusemide) and potassium supplements.

Authors:  T Y Chan; J A Critchley
Journal:  Drug Saf       Date:  1992 Mar-Apr       Impact factor: 5.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.